408 / 510
Cuidados
Continuos
407
BIBLIOGRAFÍA
NCCN. Guidelines, Palliative Care 2.2013
Zertuche T, Guell E, Fariñas O, Ranis A, Gomez-Batiste X, Pascual A. Prevalence ef advanced
terminally ill patients in an acute tertiary care hospital. 12 Congress EAPC. Lisboa Mayo 2011
Morita T, Tsunoda J Inoue S, et al. The Palliative Prognostic Index: a scoring system for survival
prediction of terminally ill cáncer patients. Support Care Cancer 1999;7:128-33.
Maltoni M, Pirovano M, Scarpi E, et al. Prediction of survival of patients terminally ill with
cáncer. Cancer 1995;75:2613-2622.
Porta J, Nabal M, Viñas J. Predicción de la supervivencia en los pacientes con neoplasias en
fase terminal.Medicina Paliativa 1997;4:5-97(2) 6-9.
Bruera A, et al. Subcutaneus morphine for dyspnea in cáncer patients . Annals of Internal
Medicine.1993. 119: 906-907.
Caraceni A et al. The impact of delirium on the short term prognosis of advanced cáncer
patients. 2000. Cancer 89: 1145-8.
Fainsinger L et al. A milticentre international study of sedation for uncontrolled symptoms in
terminally ill. Palliative Medicine 2000. 14: 257-265
Ramsay, MA, Savege, TM, Simpson, BR, Goodwin, R. Controlled sedation with alphaxalone-
alphadolone. Br Med J 1974; 2:656.
Fulton B; Sorkin EM. Propofol. An overview of its pharmacology and a review of its clinical
efficacy in intensive care sedation. Drugs 1995 Oct;50(4):636-57.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.